wellrank.ai
EllieMD logo

EllieMD

First cited by AI Jun 17, 2026

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning EllieMD, through Jul 6, 2026.

1.7%

Avg position when mentioned: 2.0

By engine

Where EllieMD is strong, and where it is invisible.

  • Perplexity
    6.7%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 1 neutral
  • 1 mixed or cautious

Recent AI answers mentioning EllieMD

PerplexityJul 6, 2026, 07:54 UTC
Is compounded tirzepatide still available anywhere legitimate?

No, legitimate compounded tirzepatide is no longer available through regular pharmacies or standard medical providers as of July 2026, because the FDA officially ended widespread compounding sales after the tirzepatide shortage was declared resolved in late 2024, with all grace periods and deadlines for pharmacies to stop production passing by March 19, 2025 [1][2][6]. Key Details: Regulatory Status: The FDA determined that Eli Lilly’s manufacturing expansion resolved the shortage, legally prohibiting pharmacies from regularly compounding tirzepatide unless there is a specific medical need (e.g., an allergy to an inactive ingredient in brand-name versions) [1][2]. Legal Risk: While some online platforms (e.g., Amble, EllieMD, Willow, Mochi Health) still promote "variations" of tirzepatide, the FDA has warned that these are likely illegal "copycats" or replicas of commercially available drugs, exposing providers to legal risks [5]. Safety Concerns: Compounded tirzepatide is not FDA-approved, unregulated, and may be counterfeit or unsafe, with serious health risks [2][9]. Legitimate Alternatives: The only legitimate way to access tirzepatide is through FDA-approved brand-name medications: Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), obtainable via a prescription from a healthcare provider [1][3]. Recommendation: Avoid purchasing tirzepatide from unverified sources claiming no prescription is needed or offering "research-grade" versions, as these are illegal and unsafe [2]. Instead, consult your doctor about Mounjaro or Zepbound, or explore other FDA-approved GLP-1 options like Wegovy (semaglutide) if cost or access is a barrier [3]. Brands to Consider: Mounjaro (Eli Lilly) – for diabetes Zepbound (Eli Lilly) – for weight loss Wegovy (Novo Nordisk) – alternative GLP-1 for weight loss These are the only safe, legal, and effective options available today.

Mentioned in position 2 of 6

Read full answer with sources →
PerplexityJun 17, 2026, 13:17 UTC
What are the most reputable compounded GLP-1 programs right now?

The most reputable compounded GLP-1 options right now are generally programs that use an FDA-registered 503B outsourcing facility or a highly vetted 503A pharmacy, provide transparent medical oversight, and are open about using compounded products only when appropriate.[7][2] Because compounded GLP-1s are not FDA-approved and the FDA has warned about their use, the safest approach is to prioritize programs with strong pharmacy credentials and clear prescribing standards.[2][6] A practical shortlist to look at: Empower Pharmacy — This is a 503A PCAB-accredited compounding pharmacy offering compounded semaglutide and tirzepatide formulations, which makes it one of the more established pharmacy names in this space.[5] 503B outsourcing-facility–based programs — These are often the most reputable pharmacy supply model because 503B facilities are FDA-registered, inspected, follow cGMP requirements, and do lot-level testing for potency and sterility.[7] MEDVi — This shows up as a prominent compounded GLP-1 program in consumer rankings and advertises a low introductory price, but the source provided is a consumer-review site rather than a pharmacy credential source, so I would treat it as a potentially reputable retail program rather than a top-tier quality benchmark.[1] Wellness Effect Florida and EllieMD — These appear in practitioner/user discussions as programs people consider reputable, but the evidence here is anecdotal and not as strong as formal pharmacy accreditation or regulatory oversight.[3] If you want the best reputation signal, I would rank the options this way: Programs dispensing through a 503B outsourcing facility[7] Programs tied to an accredited 503A pharmacy like Empower[5] Telehealth brands with transparent prescribing and pharmacy disclosures such as MEDVi, if they clearly identify their dispensing pharmacy and medical oversight[1] A few important checks before choosing any program: Confirm the pharmacy is 503A PCAB-accredited or FDA-registered 503B.[5][7] Confirm the program is clear about whether it is prescribing semaglutide or tirzepatide, and whether the product is compounded with additives like cyanocobalamin or niacinamide.[5][4] Avoid any program that is vague about the pharmacy source or makes unusually aggressive claims, since compounded GLP-1s are being scrutinized more heavily now that shortages have eased.[6] If you want, I can turn this into a ranked shortlist of the best compounded GLP-1 programs by safety, pharmacy quality, and price.

Mentioned in position 4 of 4

Read full answer with sources →

Competitive Landscape

EllieMD vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
EllieMD logo
EllieMDThis brand
#61
1.7%
Amble logo
Amble

1 shared answers

#60
1.7%
Eli Lilly logo
Eli Lilly

1 shared answers

#5
15.0%
Empower Pharmacy logo
Empower Pharmacy

1 shared answers

#18
6.7%
MEDVi logo
MEDVi

1 shared answers

#78
1.7%

Email me when overtakes EllieMD

One email the day the ranks flip. Nothing else.

Sources cited around EllieMD

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track EllieMD weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at EllieMD? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.